We think researchers at the National Institutes of Health, to assert that the cells coming from the bone marrow might combat asthma in those patients who suffer particularly in severe forms. With this new technique may be capable to lighten the load as inflammation of the lungs to get better the clinical course of disease. Stem cells should contradict to ‘asthma are known mesenchymal and are used in case of bone marrow transplantation when the immune system response is immoderate and to do that these cells act at the point of Th1 and Th2 lymphocytes.

Both lymphocytes must be in balance apart from that the patient is exposed to diseases such as, in fact, asthma affects the world some 300 million people could therefore advantage from treatment with stem cells, as shown in scientific journal Proceedings of the National Academy of Sciences.

Studies are ongoing and are carried out, experimentally, in mice in which the disease had a milder clinical course after treatment, which involved a slight exacerbation of symptoms, therefore lower secretion mucus you are so low that they can consist those of non-sufferers.

Not still reached the definition of studies and therefore we are not exclusively close the practical application of these mesenchymal cells but once again it must be said that the road is open and then close the solution.